Vision

Freeing the World of Lupus

Goals

1. 1.Unravel disease heterogeneity to support personalized diagnostics & treatments: Understanding the heterogeneity of lupus will help us break through some of the highest hurdles preventing progress of new curative treatments while accelerating the development or use of tailored therapies for lupus patients.
2. 2.Improve participation, diversity and outcomes in lupus research and clinical trials: People of color remain dramatically underrepresented in lupus clinical trials, despite being disproportionately affected by the disease. Improving participation and diversity in clinical trials will ensure that those most affected by lupus will benefit from new treatments and diagnostic
3. 3.Strengthen clinical research infrastructure: These efforts, through LRA and Lupus Therapeutics investments, will result in better trial design and conduct greater funding, as well as greater provider and patient engagement for more successful studies — leading to more effective therapies.